<!DOCTYPE html>
<html lang="en">
<head><!-- Google Tag Manager --> <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start': new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0], j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src= 'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f); })(window,document,'script','dataLayer','GTM-N4XZHNC');</script> <!-- End Google Tag Manager -->

<title>Axitinib: Treatment of Metastatic Renal Cell Cancer</title>
  <meta charset="utf-8">
  
  <link href="urology.css" rel="stylesheet">

<meta name="keywords" content="Axitinib, Axitinib renal cell cancer" >
<meta name="description" content="Pharmacology, side effects and contraindications of axitinib, from the online textbook of urology by D. Manski" >
<meta name="author" content="Dr. med. Dirk Manski" >
<meta name="copyright" content="Dirk Manski" >
<meta name="robots" content="index">
<meta name="robots" content="follow">
<meta name="viewport" content="width=device-width, initial-scale=1">
 </head>

<body><!-- Google Tag Manager (noscript) --> <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-N4XZHNC" height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript> <!-- End Google Tag Manager (noscript) --> 
<header>
    <a class="ribbon" tabindex="-1" title="back to start!" href="https://www.urology-textbook.com/index.html">
	   <h5 id="logo">urology-textbook.com</h5>
       <p>Dr. med. Dirk Manski</p>
    </a>  
</header>
<main>
<nav id="navigation">
<ul>
<li><a href="https://www.urology-textbook.com/index.html">Start</a></li>
<li><a href="https://www.urology-textbook.com/anatomy.html">Anatomy</a></li>
<li><a href="https://www.urology-textbook.com/signs-and-symptoms.html">Signs and Symptoms</a></li>
<li><a href="https://www.urology-textbook.com/examinations.html">Examinations</a></li>
<li><a href="https://www.urology-textbook.com/surgical-management.html">Surgical Management</a></li>
<li><a href="https://www.urology-textbook.com/pharmacology.html">Pharmacology</a></li>
<li><a href="https://www.urology-textbook.com/kidneys.html">Kidneys</a></li>
<li><a href="https://www.urology-textbook.com/ureters.html">Ureters</a></li>
<li><a href="https://www.urology-textbook.com/bladder.html">Bladder</a></li>
<li><a href="https://www.urology-textbook.com/prostate.html">Prostate</a></li>
<li><a href="https://www.urology-textbook.com/urethra.html">Urethra</a></li>
<li><a href="https://www.urology-textbook.com/penis.html">Penis</a></li>
<li><a href="https://www.urology-textbook.com/testes.html">Testes</a></li>
<li><a href="https://www.urology-textbook.com/adrenal-glands.html">Adrenal Glands</a></li>
<li><a href="https://www.urology-textbook.com/common-diseases.html">Common Diseases</a></li>
<li><a href="https://www.urology-textbook.com/urologic-surgery.html">Urologic Surgery</a></li>
<li><a href="https://www.urology-textbook.com/index-urology.html">Index</a></li>
<li><a href="https://www.urology-textbook.com/medical-abbreviations.html">Abbreviations</a></li>
<li><a href="https://www.urology-textbook.com/urology-news.html">News</a></li>
<li><a href="https://www.urology-textbook.com/links.html">Links</a></li>
</ul>



 
</nav>
<article>

<p id="brotkrumen">&nbsp;You are here: <a href="https://www.urology-textbook.com/index.html">Urology Textbook</a> &gt; <a href="https://www.urology-textbook.com/pharmacology.html">Drugs in Urology</a> &gt; Axitinib</p><div id="ad_h1"> <!-- ad_h1 --> <ins class="adsbygoogle"      style="display:inline-block;width:500px;height:250px"      data-ad-client="ca-pub-9284927104423861"      data-ad-slot="8746163219"></ins> </div> <h1>Axitinib: Treatment of Advanced Renal Cell Cancer</h1>

<h2>Mechanism of Action of Axitinib</h2>

<p>Axitinib is an oral potent inhibitor of VEGF receptor tyrosine kinases 1&ndash;3, which thus inhibits the intracellular signal transduction of cell growth, angiogenesis and promotes <a href="https://www.urology-textbook.com/apoptosis.html">apoptosis of tumor cells</a>. </p>

<h2>Urological Indications for Axitinib</h2>
<p>Axitinib has been approved for the <a href="https://www.urology-textbook.com/renal-cell-carcinoma-targeted-therapy.html">treatment of metastatic renal cell carcinoma</a> after previous failure of treatment with sunitinib or a cytokine (immunotherapy). Axitinib demonstrated in a randomized comparison with sorafenib an improved progression-free survival (6.7 vs. 4.7 months), this was particularly significant in patients with failure of immunotherapy (Rini et al., 2011). </p>

<h2>Pharmacokinetics of Axitinib</h2>
<p>Oral administration of axitinib. Hepatic metabolism. Half-life time is 2.5 to 6 h.</p>

<h2>Side Effects of Axitinib </h2>

<p>The most common side effects (> 20%) are diarrhea, hypertension, fatigue, dysphonia, nausea, decreased appetite, and hand-foot syndrome. For the following side effects, the incidences of grade 3/4 adverse events are specified in parentheses.</p>

<h5>Gastrointestinal tract: </h5>
<p>Diarrhea (10%), vomiting (1&ndash;2%). </p>

<h5>Skin: </h5>
<p>Hand-foot syndrome (5%), mucositis (1&ndash;2%). </p>

<h5>Circulatory system: </h5>
<p>Hypertension (15%), arterial or venous embolism (2&ndash;3%). </p>

<h5>Other side effects: </h5>
<p>Hypothyroidism, lack of appetite (3%), dehydration (2&ndash;3%), fatigue (10%). </p>

<h2>Interactions with Axitinib </h2>

<p>No concomitant medication of axitinib with strong inhibitors of CYP3A4/5 like macrolide antibiotics or ketoconazole. </p>

<h2>Contraindications of Axitinib</h2>

<ul title="contraindications of Axitinib">
<li>Axitinib is contraindicated if there are persistent side effects grade 3 and 4 despite dose reduction.</li>
<li>Severe hepatic insufficiency (Child C)</li>
<li>Pregnancy and lactation</li>
</ul><h2>Dosage of Axitinib</h2>

<p>Axitinib is started with 5&nbsp;mg 1-0-1 per os continuously. The dose is increased to 7&nbsp;mg and 10&nbsp;mg 1-0-1, if possible. If relevant adverse effects are present, the dosage is reduced to 7&nbsp;mg 1-0-1, 5&nbsp;mg 1-0-1, 3&nbsp;mg 1-0-1 and then 2&nbsp;mg 1-0-1, the alternative is a pause of medication. </p>

<h3>Clinical Controls During Therapy: </h3>

<p>Regular checks of blood count, electrolytes, liver function tests, clotting tests, blood sugar, <a href="https://www.urology-textbook.com/creatinine-serum-blood-test.html">creatinine</a>, thyroid hormones. Regular examination of the skin, oral cavity, and blood pressure. </p>

<h3>Supportive Therapy: </h3>
<p>Counter diarrhea with loperamide, prevent mucositis with regular mouthwashes, prevent hand-foot skin reaction with avoidance of mechanical load or if necessary with keratolytic or steroid ointments, treat hypertension with antihypertensive drugs, replace thyroid hormones in hypothyroidism. Without improvement of adverse effects, dose reduction or a pause of medication is necessary. </p>

<h3>Brand Names of Axitinib: </h3> 
<p>Inlyta</p>

<br>
<br><table id="navigation_unten">
<tr>
 
<td><a href="https://www.urology-textbook.com/pharmacology.html">Urologic drugs</a></td>
<td><a class="nav4" href="https://www.urology-textbook.com/index-urology.html">Index</a></td>
<td><a class="nav3" href="https://www.urology-textbook.com/bevacizumab.html">Bevacizumab</a></td>
 
</tr>
</table>

<br>
<br>
Index: <a href="https://www.urology-textbook.com/index-urology-a.html">1&ndash;9</a> <a href="https://www.urology-textbook.com/index-urology-a.html">A</a> <a href="https://www.urology-textbook.com/index-urology-b.html">B</a> <a href="https://www.urology-textbook.com/index-urology-c.html">C</a> <a href="https://www.urology-textbook.com/index-urology-d.html">D</a> <a href="https://www.urology-textbook.com/index-urology-e.html">E</a> <a href="https://www.urology-textbook.com/index-urology-f.html">F</a> <a href="https://www.urology-textbook.com/index-urology-g.html">G</a> <a href="https://www.urology-textbook.com/index-urology-h.html">H</a> <a href="https://www.urology-textbook.com/index-urology-i.html">I</a> <a href="https://www.urology-textbook.com/index-urology-j.html">J</a> <a href="https://www.urology-textbook.com/index-urology-k.html">K</a> <a href="https://www.urology-textbook.com/index-urology-l.html">L</a> <a href="https://www.urology-textbook.com/index-urology-m.html">M</a> <a href="https://www.urology-textbook.com/index-urology-n.html">N</a> <a href="https://www.urology-textbook.com/index-urology-o.html">O</a> <a href="https://www.urology-textbook.com/index-urology-p.html">P</a> <a href="https://www.urology-textbook.com/index-urology-q.html">Q</a> <a href="https://www.urology-textbook.com/index-urology-r.html">R</a> <a href="https://www.urology-textbook.com/index-urology-s.html">S</a> <a href="https://www.urology-textbook.com/index-urology-t.html">T</a> <a href="https://www.urology-textbook.com/index-urology-u.html">U</a> <a href="https://www.urology-textbook.com/index-urology-v.html">V</a> <a href="https://www.urology-textbook.com/index-urology-w.html">W</a> <a href="https://www.urology-textbook.com/index-urology-xyz.html">X Y Z</a> 

<br>
<br>
<hr>
<br>
  
<br>
<hr><h3>References</h3>



Rini, B. I.; Escudier, B.; Tomczak, P.; Kaprin, A.; 
    Szczylik, C.; Hutson, T. E.; Michaelson, M. D.; Gorbunova, V. A.; Gore, M. 
    E.; Rusakov, I. G.; Negrier, S.; Ou, Y.; Castellano, D.; Lim, H. Y.; 
    Uemura, H.; Tarazi, J.; Cella, D.; Chen, C.; Rosbrook, B.; Kim, S. &amp; 
    Motzer, R. J.
    Comparative effectiveness of axitinib versus sorafenib in 
    advanced renal cell carcinoma (AXIS): a randomised phase 3 trial.<br><em>Lancet, 
    </em><b>2011</b><i>, 378</i>, 1931-1939.

<br>
<br>
<p><img src="https://images0.urology-textbook.com/deutsch.gif">&nbsp; Deutsche Version: <a href="https://www.urologielehrbuch.de/axitinib.html">Axitinib</a></p></article>
</main>
<footer class="grid">
    <ul id="footer-nav">
    		<li>Copyright by Dr. med. Dirk Manski </li>
		<li><a href="https://www.urology-textbook.com/privacy-policy.html">Privacy policy</a></li>
		<li><a href="https://www.urology-textbook.com/disclaimer.html">Disclaimer</a></li>
	</ul>
	<a class="steady-login-button" data-size="medium" data-language="en" style="display: none;"></a>
	
<img src="https://vg08.met.vgwort.de/na/5d52ef64c3dd48aa9cc8b044b68924e4" width="1" height="1" alt="">


</footer>
</body>
</html>
